Publication | Open Access
PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical Models
456
Citations
35
References
2015
Year
Drug TargetHealth SciencesPreclinical ModelsMedicineRational Drug DesignMechanism Of ActionMolecular BiologyOvercomes ResistanceAnti-cancer AgentAlk/ros1 InhibitorPharmacologyDrug DiscoveryDrug Resistance
| Year | Citations | |
|---|---|---|
Page 1
Page 1